Details of the Drug Pharmacogenomic Perturbation Atlas
General Information of Drug (ID: DM2UZL9)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms |
bufexamac; 2438-72-4; Bufexamic acid; 2-(4-Butoxyphenyl)-N-hydroxyacetamide; Parfenac; Parfenal; Feximac; Mofenar; Malipuran; Droxaryl; Bufexamacum; Flogicid; Bufexamaco; Paraderm; Norfemac; Anderm; 4-Butoxy-N-hydroxybenzeneacetamide; p-Butoxyphenylacetohydroxamic acid; 4-Butoxyphenylacetohydroxamic acid; Flogocid N plastigel; Acide p-butoxyphenylacethydroxamique; 2-(p-Butoxyphenyl)-acetohydroxamic acid; Bufessamac [DCIT]; Bufexamacum [INN-Latin]; Bufexamaco [INN-Spanish]; CP 1044 J3; UNII-4T3C38J78L; Benzeneacetamide, 4-butoxy-N-hyd
| |||||
| Cross-matching ID | ||||||
Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pharmacogenomic Perturbation Across Diseases and Tissues
|
Breast
Breast adenocarcinoma
Prostate
Prostate carcinoma
|
||||||||||||||||||||||||||||||||||||||||||
